Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market buy Director bought 174,967 shares at $7.41 ($1,296,505)
  2. 4 Other acquisition Director acquired 115,315 shares (other)
  3. 4 Other acquisition Director acquired 584 shares (other)
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale MOATAZEDI DAVID sold 6,110 shares at $8.47 ($51,752)
  6. 4 Open-market sale MOATAZEDI DAVID sold 64,211 shares at $8.47 ($543,797)
  7. 4 Open-market sale Avelar Rui sold 14,906 shares at $8.47 ($126,237)
  8. 4 Open-market sale 10% owner sold 1,850,000 shares at $8.40 ($15,540,000)
  9. 4 Open-market sale 10% owner sold 2,187,511 shares at $8.50 ($18,593,844)
  10. 4 Open-market sale 10% owner sold 37,043 shares at $11.04 ($408,955)
  11. 4 Grant or award Director acquired 8,293 shares (grant or award)
  12. 4 Grant or award Director acquired 8,293 shares (grant or award)
  13. 4 Grant or award Director acquired 8,293 shares (grant or award)
  14. 4 Grant or award Director acquired 8,293 shares (grant or award)
  15. 4 Grant or award Director acquired 8,293 shares (grant or award)
  16. 4 Grant or award Director acquired 8,293 shares (grant or award)
  17. 4 Grant or award Director acquired 8,293 shares (grant or award)
  18. 4 Grant or award Avelar Rui acquired 97,642 shares (grant or award)
  19. 4 Grant or award MOATAZEDI DAVID acquired 187,927 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 62,642 shares (grant or award)

Page 5 of 13 · 252 filings